Sitting in a Cardiac Unit in the hospital, every bad choice you've ever made, every skipped shot of insulin, every Krispy Kreme doughnut, and every bag of Doritos come back to haunt you...
Biodel Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's new drug application seeking approval to market VIAject(R) for the treatment of diabetes. VIAject(R) is Biodel's proprietary formulation of recombinant human insulin that is designed to be absorbed into the blood faster than currently marketed rapid-acting insulin analogs...
On Friday over its diabetes drug Avandia, charging a decade of false advertising and seeking compensation on behalf of patients and providers in California. MercuryNews reports the county claims the drugmaker made billions of dollars on Avandia, which caused heart attacks and strokes....